Kulsum Jamal,
- Researcher, Department of Biomedical Sciences, Jamia Hamdard University, New Delhi, India
Abstract
Bacterial and fungal pathogens rarely act as solitary invaders. Instead, they engage in sophisticated chemical communication known as quorum sensing (QS) to coordinate population-wide behaviours and construct structured, multicellular biofilm communities. These biofilms, composed of extracellular polymeric substances, not only facilitate microbial persistence on biotic and abiotic surfaces but also confer remarkable protection against host immune defenses and antimicrobial therapies. QS systems act as central regulators of biofilm dynamics, orchestrating processes from initial attachment to maturation and dispersal, thereby enabling pathogens to adapt to fluctuating environments and colonize diverse niches. The interplay between QS and biofilm formation has profound clinical implications, particularly in chronic infections such as cystic fibrosis lung disease, endocarditis, and persistent device-related infections where conventional antimicrobial strategies often fail. Moreover, biofilm-mediated tolerance contributes significantly to the global antimicrobial resistance (AMR) crisis. This review explores the molecular mechanisms linking QS and biofilm development, providing illustrative case studies from clinically important bacteria (Pseudomonas aeruginosa, Staphylococcus aureus) and fungi (Candida albicans). It further examines the diagnostic and therapeutic challenges posed by QS-regulated biofilms, with emphasis on emerging strategies including quorum sensing inhibitors, matrix-degrading enzymes, engineered biomaterials, phage therapy, and host-directed interventions. Finally, we highlight key research gaps, evolutionary considerations, and translational hurdles that must be addressed to harness anti-QS and anti-biofilm strategies in clinical practice. Together, these insights position quorum sensing and biofilm biology as an evolving frontier in infectious disease management.
Keywords: Quorum sensing, biofilm, antimicrobial resistance, Pseudomonas aeruginosa, chronic infections
[This article belongs to International Journal of Pathogens ]
Kulsum Jamal. Quorum Sensing and Biofilm Dynamics in Pathogens: An Evolving Frontier in Infectious Disease. International Journal of Pathogens. 2026; 03(01):18-23.
Kulsum Jamal. Quorum Sensing and Biofilm Dynamics in Pathogens: An Evolving Frontier in Infectious Disease. International Journal of Pathogens. 2026; 03(01):18-23. Available from: https://journals.stmjournals.com/ijpg/article=2026/view=237790
References
1. Zhao A, Sun J, Liu Y. Understanding bacterial biofilms: From definition to treatment strategies. Front. Cell. Infect. Microbiol. 2023 Apr 6;13:1137947. 2. Miranda SW, Asfahl KL, Dandekar AA, Greenberg EP. Pseudomonas aeruginosa Quorum Sensing. Adv Exp Med Biol. 2022;1386:95-115. doi: 10.1007/978-3-031-08491-1_4. PMID: 36258070; PMCID: PMC9942581. 3. Horváth ZM, Viter R, Radziņš O, Thor A, Kolisnyk T, Mohylyuk V. PEEK implants for cranioplasty: A mapping review of 3D printing, surface functionalisation, and clinical performance Gaps. Materials Advances. 2026. 4. Qin S, Xiao W, Zhou C, Pu Q, Deng X, Lan L, et al. Pseudomonas aeruginosa: pathogenesis, virulence factors, antibiotic resistance, interaction with host, technology advances and emerging therapeutics. Signal Transduct Target Ther. 2022 Jun 25;7(1):199. 5. Simanek KA, Schumacher ML, Mallery CP, Shen S, Li L, Paczkowski JE. Quorum-sensing synthase mutations re-calibrate autoinducer concentrations in clinical isolates of Pseudomonas aeruginosa to enhance pathogenesis. Nat Commun. 2023 Dec 2;14(1):7986. 6. Dutt Y, Dhiman R, Singh T, Vibhuti A, Gupta A, Pandey RP, et al. The association between biofilm formation and antimicrobial resistance with possible ingenious bio-remedial approaches. Antibiotics (Basel). 2022 Jul 11;11(7):930. doi: 10.3390/antibiotics11070930. PMID: 35884186; PMCID: PMC9312340. 7. Van Hoogstraten SW, Kuik C, Arts JJ, Cillero-Pastor B. Molecular imaging of bacterial biofilms—A systematic review. Crit Rev Microbiol. 2024 Nov 1;50(6):971-92. 8. Hetta HF, Ramadan YN, Rashed ZI, Alharbi AA, Alsharef S, Alkindy TT, et al. Quorum sensing inhibitors: an alternative strategy to win the battle against multidrug-resistant (MDR) bacteria. Molecules. 2024 Jul 24;29(15):3466. 9. Alum EU, Gulumbe BH, Izah SC, Uti DE, Aja PM, Igwenyi IO, et al. Natural product-based inhibitors of quorum sensing: A novel approach to combat antibiotic resistance. Biochem Biophys Rep. 2025 Sep 1;43:102111. 10. Coolahan M, Jennings C, Doyle R. A review of quorum sensing and its role in mediating microbial interactions. Commun Biol. 2025. 11. Stewart PS, Costerton JW. Antibiotic resistance of bacteria in biofilms. The lancet. 2001 Jul 14;358(9276):135–8. 12. Ho CS, Wong CT, Aung TT, Lakshminarayanan R, Mehta JS, Rauz S, et al. Antimicrobial resistance: A concise update. The Lancet Microbe. 2025 Jan 1;6(1). 13. Ahmed SK, Rahman M, Hossain T, Karim R. Antimicrobial resistance: Global impacts, challenges, and future perspectives. Res Rev Antimicrob Resist. 2024. 14. Fu T, Wright RC, Gifford DR, Knight CG, Brockhurst MA. Inflammation-like environments limit the loss of quorum sensing in Pseudomonas aeruginosa. Msystems. 2025 Aug 19;10(8):e01722–24. 15. Grari O, Ezrari S, El Yandouzi I, Benaissa E, Lahlou YB, Lahmer M, et al. A comprehensive review on biofilm-associated infections: Mechanisms, diagnostic challenges, and innovative therapeutic strategies. The Microbe. 2025 Sep 1;8:100436.
International Journal of Pathogens
| Volume | 03 |
| Issue | 01 |
| Received | 24/09/2025 |
| Accepted | 16/11/2025 |
| Published | 25/01/2026 |
| Publication Time | 123 Days |
Login
PlumX Metrics